Geode Capital Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Sell |
315,421
-455,486
| -59% | -$189K | ﹤0.01% | 3996 |
|
|
2025
Q1 | $480K | Buy |
770,907
+30,801
| +4% | +$19.2K | ﹤0.01% | 3558 |
|
|
2024
Q4 | $1.24M | Buy |
740,106
+39,259
| +6% | +$65.6K | ﹤0.01% | 3292 |
|
|
2024
Q3 | $1.28M | Buy |
700,847
+441
| +0.1% | +$803 | ﹤0.01% | 3270 |
|
|
2024
Q2 | $4.22M | Buy |
700,406
+95,692
| +16% | +$577K | ﹤0.01% | 2823 |
|
|
2024
Q1 | $6.74M | Buy |
604,714
+19,680
| +3% | +$219K | ﹤0.01% | 2542 |
|
|
2023
Q4 | $8.71M | Buy |
585,034
+141,967
| +32% | +$2.11M | ﹤0.01% | 2417 |
|
|
2023
Q3 | $2.13M | Sell |
443,067
-1,231
| -0.3% | -$5.91K | ﹤0.01% | 3061 |
|
|
2023
Q2 | $3.34M | Buy |
444,298
+23,254
| +6% | +$175K | ﹤0.01% | 2912 |
|
|
2023
Q1 | $1.9M | Buy |
421,044
+8,735
| +2% | +$39.5K | ﹤0.01% | 3053 |
|
|
2022
Q4 | $4.65M | Buy |
412,309
+18,988
| +5% | +$214K | ﹤0.01% | 2708 |
|
|
2022
Q3 | $3.76M | Buy |
393,321
+13,121
| +3% | +$126K | ﹤0.01% | 2822 |
|
|
2022
Q2 | $3.08M | Buy |
380,200
+59,859
| +19% | +$484K | ﹤0.01% | 2958 |
|
|
2022
Q1 | $5.41M | Sell |
320,341
-19,505
| -6% | -$330K | ﹤0.01% | 2757 |
|
|
2021
Q4 | $7.3M | Sell |
339,846
-20,500
| -6% | -$441K | ﹤0.01% | 2658 |
|
|
2021
Q3 | $26.6M | Buy |
360,346
+82,069
| +29% | +$6.06M | ﹤0.01% | 1758 |
|
|
2021
Q2 | $15.2M | Buy |
278,277
+6,260
| +2% | +$342K | ﹤0.01% | 2159 |
|
|
2021
Q1 | $20.1M | Buy |
272,017
+91,149
| +50% | +$6.72M | ﹤0.01% | 1879 |
|
|
2020
Q4 | $15.6M | Buy |
180,868
+26,239
| +17% | +$2.26M | ﹤0.01% | 1881 |
|
|
2020
Q3 | $5.84M | Buy |
+154,629
| New | +$5.84M | ﹤0.01% | 2301 |
|